Related Experiment Video
Updated: Aug 2, 2026
12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
The Toronto Tri-Hospital Gestational Diabetes Project. A preliminary review
M Sermer1, C D Naylor, D Farine
1Department of Obstetrics, University of Toronto, Canada.
Diabetes Care
|August 15, 1998
Summary
Mild carbohydrate intolerance in pregnancy, even below gestational diabetes mellitus (GDM) criteria, increases risks for adverse outcomes. Adjusting screening test thresholds based on meal timing can improve GDM detection efficiency.
Area of Science:
- Obstetrics and Gynecology
- Endocrinology
- Perinatal Medicine
Background:
- Gestational diabetes mellitus (GDM) diagnosis criteria may miss women with borderline carbohydrate intolerance.
- Understanding maternal-fetal outcomes in these borderline cases is crucial for optimizing pregnancy care.
Purpose of the Study:
- To assess maternal-fetal outcomes in pregnant women with increasing carbohydrate intolerance below GDM thresholds.
- To examine the relationship between birth weight, delivery mode, and GDM status.
- To develop more efficient screening strategies for GDM detection.
Main Methods:
- Prospective analytic cohort study of nondiabetic pregnant women aged 24+ years.
- Utilized 50-g glucose challenge test (GCT) and 100-g oral glucose tolerance test (OGTT).
- Recorded risk factors, time since last meal, and maternal-fetal outcomes, including delivery mode.
Main Results:
- Increasing carbohydrate intolerance, even without overt GDM, correlated with higher rates of cesarean section, preeclampsia, macrosomia, and longer hospital stays.
- Untreated borderline GDM was linked to increased macrosomia and cesarean delivery rates compared to normoglycemic controls.
- Adjusting GCT thresholds based on time since last meal improved screening efficiency and reduced misclassification.
Conclusions:
- Maternal carbohydrate intolerance shows a graded association with adverse pregnancy outcomes.
- Infant macrosomia is a significant factor in high cesarean delivery rates for women with untreated borderline GDM.
- Optimizing GDM screening by incorporating meal timing can enhance early detection and management.
Related Concept Videos
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:20Pathophysiology of Diabetes
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
01:26Diabetes Mellitus: Introduction
Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:25Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
01:29Hyperglycemia
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...